Pharmaceutical Executive
As new ICH GCP draft guidelines now require root cause analysis, novel methods for risk analysis and triage must be adopted in drug development.
Clara Heering
Advertisement
Articles by Clara Heering
Advertisement
Latest Updated Articles
What Errors Do We Miss in Clinical Trials?March 8th 2016
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Wegovy HD Injectable Under Accelerated Approval
2
Pharmaceutical Executive Daily: FDA Approves Wegovy HD
3
Pharma M&A Roundup: Novartis to Acquire Pan-Mutant-Selective PI3Kα Inhibitor from Synnovation Therapeutics, Collegium to Acquire Azstarys from Corium Therapeutics
4
What Are the ‘Last Mile Issues’ Impacting Pharma?
5